Rivaroxaban IP 20MG
Rivajon (rivaroxaban) is indicated to reduce the risk of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (AF). Rivajon is indicated for the treatment of deep vein thrombosis (DVT). Rivajon is indicated for the treatment of pulmonary embolism (PE).
Rivaroxaban is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults. Rivaroxaban is also used to prevent DVT and PE from happening again after initial treatment is completed in adults.
- Back pain.
- bloody stools.
- bowel or bladder dysfunction.
- coughing up blood.
- difficulty with breathing or swallowing.
- increased menstrual flow or vaginal bleeding.
- leg weakness.